The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-phenyl-5,7-dihydroxy-8-(2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one ID: ALA4296686
PubChem CID: 66934034
Max Phase: Preclinical
Molecular Formula: C21H22ClNO5
Molecular Weight: 367.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)[C@@H]1CO.Cl
Standard InChI: InChI=1S/C21H21NO5.ClH/c1-22-8-7-13(14(22)11-23)19-15(24)9-16(25)20-17(26)10-18(27-21(19)20)12-5-3-2-4-6-12;/h2-6,9-10,13-14,23-25H,7-8,11H2,1H3;1H/t13-,14+;/m1./s1
Standard InChI Key: QUQSBMYCYZBVNI-DFQHDRSWSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
14.8247 -7.9870 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.3773 -4.2498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3762 -5.0772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0910 -5.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0892 -3.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8045 -4.2461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8034 -5.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5203 -5.4945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2429 -5.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2441 -4.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5226 -3.8284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5227 -3.0034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9523 -5.4956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9485 -6.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6610 -6.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3776 -6.3255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3773 -5.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6643 -5.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0867 -3.0121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6614 -5.4891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0956 -6.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4281 -6.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6827 -7.5844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5078 -7.5847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7628 -6.8001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9925 -8.2522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5475 -6.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1604 -7.0976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
9 13 1 0
5 19 1 0
3 20 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
21 4 1 1
24 26 1 0
25 27 1 6
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.40Molecular Weight (Monoisotopic): 367.1420AlogP: 2.65#Rotatable Bonds: 3Polar Surface Area: 94.14Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.60CX Basic pKa: 7.42CX LogP: 1.80CX LogD: 1.72Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: 1.40
References 1. Hole AJ, Baumli S, Shao H, Shi S, Huang S, Pepper C, Fischer PM, Wang S, Endicott JA, Noble ME.. (2013) Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity., 56 (3): [PMID:23252711 ] [10.1021/jm301495v ]